Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference7 articles.
1. Kralickova P, Milota T, Litzman J, Malkusova I, Jilek D, Petanova J, et al. CVID-associated tumors: Czech nationwide study focused on epidemiology, immunology, and genetic background in a cohort of patients with CVID. Front Immunol. 2019;9:3135.
2. National Cancer Institute Center for Cancer Research. Inflammatory Myofibroblastic Tumor (IMT). What is inflammatory myofibroblastic tumor? NIH. 2019. https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/inflammatory-myofibroblastic-tumor. Accessed 7 Jul 2020.
3. Özbalak M, Torun ES, Özdemirli M, Uçar AR, Akpınar TS, Taşçıoğlu C, et al. Inflammatory myofibroblastic tumor mimicking a relapse in a patient with Hodgkin’s lymphoma: report of an unusual case and review of the literature. Clin Case Rep. 2017;5(6):945–9.
4. Sandoval L, França MV, Sanmartino D, Zattar Piazera F. ALK negative inflammatory myofibroblastic tumor synchronous with classical Hodgkin lymphoma. Case Rep Oncol. 2019;12(1):119–25.
5. Antonescu CR, Suurmeijer AJ, Zhang L, Sung YS, Jungbluth A, Travis W, et al. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement. Am J Surg Pathol. 2015;39(7):957–67.